ACACA and breast cancer: Our hypothesis is supported by recent studies on breast cancer and endothelial cells, in which the ratio of PUFA-containing phospholipids was increased when fatty acid biosynthesis was blocked with the acetyl-CoA carboxylase (ACC) inhibitor soraphen A50,51.